AI-Native Scoping Reviews & Evidence Mapping

Retraction does not end the life of bad science — this review shows how misconduct-driven papers can keep shaping citations, clinical thinking, and public belief long after formal withdrawal. Drawing on 129 references, it maps why retractions fail, where the system breaks, and why the hidden afterlife of invalid research matters far more than most readers realize.

This paper shows that prolonged fasting is not a single “healthy” or “harmful” phenomenon, but a powerful biological stressor that can trigger major systemic remodeling while producing very different clinical effects depending on duration, population, and context. It is worth reading because it maps where fasting may improve metabolism and perioperative care, where it may carry real risk, and how a broad, mixed literature can be turned into a clinically usable evidence landscape.

This paper shows that OMT is not confined to musculoskeletal symptom relief, but sits at the intersection of pain modulation, autonomic regulation, neonatal care, and selected inpatient applications, with its strongest recurrent signal in chronic low back pain. The full read is worth it because it separates where the evidence is genuinely convincing, where mechanistic findings deepen the clinical story, and where the field still rests on mixed or low-certainty data.

This paper shows that chronotype is not a trivial lifestyle preference, but a biologically meaningful pattern linked across a huge evidence base to mood, sleep, metabolism, behavior, and real-world performance. The full paper is worth reading because it clarifies how strongly eveningness clusters with risk, where the signal is most consistent, and whether aligning life with one’s internal clock could become a practical lever for better health and longevity.

The aim of this review is to synthesize the current scientific literature regarding the biological activities, clinical efficacy, and safety profile of guarana across human, animal, and in vitro models. The review utilises 167 original studies with 251199 total participants (topic deduplicated ΣN). The evidence map suggests that guarana has its clearest human signals in acute cognitive performance and metabolic regulation, alongside notable safety concerns at higher stimulant exposures. In particular, guarana-containing interventions were associated with body fat reductions of 5.53% at 4 weeks…

This paper shows that women usually live longer than men, but that extra survival often comes with more years lived with disability, multimorbidity, and reduced independence rather than more healthy years. The full paper is worth reading because it shows where the female advantage remains strong, where it weakens, and which conditions and life circumstances most clearly explain the difference.

This paper shows that economic inequality is not just a background social problem, but a force linked to worse health, weaker trust, more violence, and poorer collective resilience. The full paper is worth reading because it shows how inequality affects real outcomes across medicine, behavior, and society, and why both personal hardship and the perception of unfairness seem to matter.

This paper shows that daylight saving time is not a harmless calendar ritual: the clock changes align with measurable spikes in mortality, suicide, cardiovascular events, sleep loss, and road danger, with the spring and autumn transitions carrying distinct risks. Read the full paper to see where the strongest signals emerge, which outcomes remain inconsistent, and why the evidence increasingly points toward ending biannual clock changes rather than treating them as a neutral social habit.

This paper shows that coffee is not a proven anti-aging therapy, yet the mapped evidence still suggests a biologically plausible link to longer survival through oxidative-stress and insulin/IGF-1 pathways, with human data pointing to modest benefit rather than clear harm. Read the full text to see where the real signal lies, which findings are only indirect or genotype-specific, and why the apparent longevity story of coffee is much more nuanced than popular health claims suggest.

Y chromosome loss emerges in this paper not as a passive marker of ageing, but as a potentially central male-specific biological signal linked to cardiovascular death, cancer progression, neurodegeneration, and immune dysfunction across a massive evidence base. The full paper is worth reading because it shows where this signal is strongest, how consistent it is across 1,048 original studies, and why LOY may become both a prognostic biomarker and a future therapeutic target.